| Tolerability of Pharmaton PHL 00747 in Healthy, Young Female Subjects of Child-bearing Potential (NCT02183285) | Boehringer Ingelheim | 2003-11-01 |
| Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors (NCT02171637) | Boehringer Ingelheim | 2003-11-01 |
| An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects (NCT00144261) | Boehringer Ingelheim | 2003-11-01 |
| Bioavailability of Tipranavir/Ritonavir Paediatric Solution Compared to Tipranavir/Ritonavir Capsules in Healthy Female and Male Subjects (NCT02251158) | Boehringer Ingelheim | 2003-10-01 |
| Efficacy and Tolerability of Bisacodyl Sugar Coated Tablets, Simeticone Chewing Tablets and Their Combination in Constipation and Bloatedness (NCT02211976) | Boehringer Ingelheim | 2003-10-01 |
| Dose Escalation of Bivatuzumab Mertansine in Patients With Advanced Squamous Cell Carcinoma of the Head and Neck or Esophagus (NCT02254044) | Boehringer Ingelheim | 2003-10-01 |
| Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency (NCT02249442) | Boehringer Ingelheim | 2003-10-01 |
| Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension (NCT00659607) | Boehringer Ingelheim | 2003-09-01 |
| Micardis® / MicardisPlus® Program for Therapy Optimization With Telmisartan in Cardiovascular Diseases (PROTEKT) (NCT02262637) | Boehringer Ingelheim | 2003-09-01 |
| Pilot Study Comparing Tiotropium (Spiriva) to Salmeterol (Serevent) Plus Fluticasone (Flixotide) in Chronic Obstructive Pulmonary Disease (COPD) (NCT00239499) | Boehringer Ingelheim | 2003-09-01 |
| Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension (NCT02242838) | Boehringer Ingelheim | 2003-09-01 |
| PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin (NCT01227629) | Boehringer Ingelheim | 2003-09-01 |
| Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension (NCT02242812) | Boehringer Ingelheim | 2003-09-01 |
| Free Combinations of Tiotropium Inhalation Powder Capsule + Salmeterol Metered Dose Inhaler, Tiotropium Inhalation Powder Capsule and Salmeterol Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02242253) | Boehringer Ingelheim | 2003-09-01 |
| A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients (NCT00240448) | Boehringer Ingelheim | 2003-09-01 |
| PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes (NCT00153062) | Boehringer Ingelheim | 2003-08-01 |
| Bioavailability of BIBR 953 ZW Under Influence of Food in Healthy Subjects (NCT02170597) | Boehringer Ingelheim | 2003-08-01 |
| Effects of Single-dose and Steady-state TPV/r on the Steady-state Pharmacokinetics of Clarithromycin and a Preliminary Assessment of the Effects of a Standard High-fat Test Meal on the Steady-state Pharmacokinetics of Tipranavir (NCT02251769) | Boehringer Ingelheim | 2003-08-01 |
| Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BEA 2180 BR in Healthy Male Subjects (NCT02263976) | Boehringer Ingelheim | 2003-08-01 |
| Effects of Steady-state TPV/RTV on the Single-dose Pharmacokinetics of Rifabutin and the Effects of Single-dose Rifabutin on the Steady-state Pharmacokinetics of TPV in Healthy Adult Volunteers (NCT02251171) | Boehringer Ingelheim | 2003-08-01 |
| A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study) (NCT00168857) | Boehringer Ingelheim | 2003-07-09 |
| Pharmacokinetics of Atorvastatin With Tipranavir/Ritonavir and the Effect of Antacid on the Pharmacokinetics of Single-Dose Tipranavir/Ritonavir in Healthy Volunteers (NCT02245269) | Boehringer Ingelheim | 2003-07-01 |
| Pharmacokinetics of Tipranavir/Ritonavir and Its Metabolites in Healthy Male Subjects (NCT02253797) | Boehringer Ingelheim | 2003-07-01 |
| Dose Escalation of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Recurrent or Metastatic Breast Cancer (NCT02254031) | Boehringer Ingelheim | 2003-07-01 |
| A Randomised, Double-blind, Placebo-controlled, 12 Week Trial to Evaluate the Effect of Tiotropium Inhalation Capsules (Spiriva) on the Magnitude of Exercise, Measured Using an Accelerometer, in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT00144326) | Boehringer Ingelheim | 2003-07-01 |
| Efficacy and Safety (Including 24-hour Holter Monitoring) of Tiotropium Inhalation Capsules in Patients With COPD (NCT00239460) | Boehringer Ingelheim | 2003-07-01 |
| Safety and Efficacy of Mobic® Ampoules in the Initiation of Treatment of Painful Exacerbations of Osteoarthritis, Rheumatoid Arthritis and Other Similar Painful Inflammatory Conditions (NCT02184052) | Boehringer Ingelheim | 2003-07-01 |
| Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease (NCT00240409) | Boehringer Ingelheim | 2003-07-01 |
| Open Label Study of NVP+CBV Treatment in Women Who Have Received sdNVP for the pMTCT of HIV (NCT00144157) | Boehringer Ingelheim | 2003-06-01 |
| An Dose Escalation Study of Treatment With BIBF 1120 in Patients With Advanced Solid Tumours (NCT02182206) | Boehringer Ingelheim | 2003-06-01 |
| Tolerability and Safety of Duloxetine BID in Healthy Female Subjects (NCT02232542) | Boehringer Ingelheim | 2003-06-01 |
| Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS (NCT02191215) | Boehringer Ingelheim | 2003-06-01 |
| Influence of Different Degrees of Renal Impairment on the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of BIBT 986 BS in Subjects With Normal Renal Function and Patients With Different Degrees of Renal Impairment (NCT02254070) | Boehringer Ingelheim | 2003-06-01 |
| A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD) (NCT00239434) | Boehringer Ingelheim | 2003-06-01 |
| Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers (NCT02195466) | Boehringer Ingelheim | 2003-06-01 |
| Pharmacokinetics and Pharmacodynamics of BIWH 3 in Healthy Duffy Positive vs. Duffy Negative Male Volunteers (NCT02249117) | Boehringer Ingelheim | 2003-06-01 |
| A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) (NCT00148486) | Boehringer Ingelheim | 2003-06-01 |
| Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH) (NCT02245503) | Boehringer Ingelheim | 2003-05-01 |
| Efficacy and Safety of Meloxicam (Mobicox®) in Mexican Population With Rheumatic Diseases (NCT02184039) | Boehringer Ingelheim | 2003-05-01 |
| Efficacy and Safety of 24 Weeks of Oral Treatment With BIIL 284 BS in Adult and Pediatric Patients (NCT00060801) | Boehringer Ingelheim | 2003-05-01 |
| Single Rising Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Spray Dried BIBN 4096 BS After Inhalation Administration in Healthy Male and Female Volunteers (NCT02199860) | Boehringer Ingelheim | 2003-05-01 |
| Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection (NCT00062660) | Boehringer Ingelheim | 2003-05-01 |
| Efficacy, Safety and Pharmacokinetics of BIRB 796 BS Tablets in Patients With Active Rheumatoid Arthritis (NCT02214888) | Boehringer Ingelheim | 2003-05-01 |
| Safety, Tolerability and Pharmacokinetics of KUC 7483 Tablets in Healthy Male Volunteers (NCT02259907) | Boehringer Ingelheim | 2003-05-01 |
| Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD) (NCT02176200) | Boehringer Ingelheim | 2003-04-01 |
| An Dose Escalation Study of BIBF 1120 Administered in Patients With Relapsed or Refractory Multiple Myeloma (NCT02182141) | Boehringer Ingelheim | 2003-04-01 |
| Berodual® Respimat® vs Metered Dose Inhaler in Patients With Chronic Obstructive Pulmonary Disease (NCT02176187) | Boehringer Ingelheim | 2003-04-01 |
| 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (NCT00153023) | Boehringer Ingelheim | 2003-04-01 |
| Rt-PA in the Treatment of Acute Ischemic Stroke (NCT00153036) | Boehringer Ingelheim | 2003-04-01 |
| Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects (NCT02262572) | Boehringer Ingelheim | 2003-04-01 |
| Bioequivalence Study of UH-AC 62 XX Tablets Compared With the Capsule Formulations in Healthy Volunteers (NCT02181907) | Boehringer Ingelheim | 2003-03-01 |
| A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations (NCT00148512) | Boehringer Ingelheim | 2003-03-01 |
| Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers (NCT02257008) | Boehringer Ingelheim | 2003-03-01 |
| Dual Boosted - Protease Inhibitor (PI) Pharmacokinetics (PK) Trial (Tipranavir / Ritonavir) in Highly Treatment-experienced HIV-1 Infected Patients (NCT00056641) | Boehringer Ingelheim | 2003-02-18 |
| Tiotropium / Respimat One-Year Study (NCT00168831) | Boehringer Ingelheim | 2003-02-01 |
| Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome (NCT00144209) | Boehringer Ingelheim | 2003-02-01 |
| Pharmacodynamic Effects, Safety and Tolerability of Cilobradine, Compared to Metoprolol Succinate and Placebo in Healthy Volunteers (NCT02264002) | Boehringer Ingelheim | 2003-02-01 |
| Tolerability and Pharmacokinetics/-Dynamics of BIBT 986 BS in Healthy Male Subjects (NCT02254083) | Boehringer Ingelheim | 2003-02-01 |
| Protocol for Post Marketing Surveillance of Actilyse Vial (NCT02229799) | Boehringer Ingelheim | 2003-02-01 |
| Post Marketing Surveillance to Monitor the Safety and Efficacy of Metalyse® in Korean Patients With Acute Myocardial Infarction (NCT02206646) | Boehringer Ingelheim | 2003-02-01 |
| Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2) (NCT00144170) | Boehringer Ingelheim | 2003-02-01 |
| Study to Evaluate the Presence of a Hangover Effect in Healthy Adults After Administration of Songha® Night Tablets (NCT02273453) | Boehringer Ingelheim | 2003-02-01 |
| An Evaluation of Three Doses of NS 2330 in Patients With Mild to Moderate Dementia of the Alzheimer's Type (NCT00153010) | Boehringer Ingelheim | 2003-02-01 |
| Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes (NCT00240422) | Boehringer Ingelheim | 2003-02-01 |
| Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects (NCT02273557) | Boehringer Ingelheim | 2003-01-01 |
| Post Marketing Surveillance Study in Rehabilitation Clinics (Cardio, Nephro, Diabetes, Pulmo) (NCT02262611) | Boehringer Ingelheim | 2003-01-01 |
| A Study of Single Dose Nevirapine (NVP) Combined With Combivir® for the Prevention of Mother to Child Transmission (pMTCT) - Treatment Options Preservation Study (TOPS) (NCT00144183) | Boehringer Ingelheim | 2003-01-01 |
| Tolerability of Sifrol® in Ambulatory Patients Suffering From Parkinson's Disease (NCT02248207) | Boehringer Ingelheim | 2003-01-01 |
| SMOOTH - Blood Pressure Control in Diabetic/Obese Patients (NCT00239538) | Boehringer Ingelheim | 2003-01-01 |
| Study to Characterise the Effect of Tamsulosin on Lower Urinary Tract Symptoms (LUTS) and Detrusor Motor Activity in Patients Affected by Benign Prostatic Hyperplasia (BPH) and Storage Urinary Symptoms (NCT02245490) | Boehringer Ingelheim | 2003-01-01 |
| Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST) (NCT00054717) | Boehringer Ingelheim | 2003-01-01 |
| Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise (NCT00946829) | Boehringer Ingelheim | 2003-01-01 |
| Tiotropium / Respimat One-Year Study (NCT00168844) | Boehringer Ingelheim | 2003-01-01 |
| INNOVATION Study - Telmisartan (Micardis) in Incipient Diabetic Nephropathy (NCT00153088) | Boehringer Ingelheim | 2003-01-01 |
| Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension (NCT02242357) | Boehringer Ingelheim | 2003-01-01 |
| Safe Implementation of Thrombolysis in Stroke - Monitoring Study (NCT02229812) | Boehringer Ingelheim | 2002-12-01 |
| A Comparison of Telmisartan + Hydrochlorothiazide With Amlodipine + Hydrochlorothiazide in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension (ATHOS Study) (NCT00240474) | Boehringer Ingelheim | 2002-12-01 |
| Safety Trial of Atrovent® in Pediatric Patients With Rhinorrhea Associated With a Common Cold or Allergy (NCT02238210) | Boehringer Ingelheim | 2002-12-01 |
| Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients (NCT00144339) | Boehringer Ingelheim | 2002-12-01 |
| Effect of BIBT 986 Followed by BIBT 986 Given as IV Infusion on Tissue Factor Triggered Coagulation in Healthy Male Volunteers (NCT02259881) | Boehringer Ingelheim | 2002-12-01 |
| Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal). (NCT00239408) | Boehringer Ingelheim | 2002-12-01 |
| Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in COPD (NCT00239447) | Boehringer Ingelheim | 2002-11-26 |
| BIBR 953 ZW in Healthy Elderly Subjects (NCT02173730) | Boehringer Ingelheim | 2002-11-01 |
| Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers (NCT02253953) | Boehringer Ingelheim | 2002-11-01 |
| 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD (NCT00239473) | Boehringer Ingelheim | 2002-11-01 |
| BIBR 1048 Dose Range Finding Study in Prevention of Venous Thromboembolism in Patients With Primary Elective Total Hip or Knee Replacement Surgery (NCT01225822) | Boehringer Ingelheim | 2002-11-01 |
| To Determine the Maximum Tolerated Dose (MTD) of BIBF 1120 in Patients With Solid Tumours (NCT01951846) | Boehringer Ingelheim | 2002-11-01 |
| 12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD (NCT00240435) | Boehringer Ingelheim | 2002-11-01 |
| PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN (NCT00274599) | Boehringer Ingelheim | 2002-10-09 |
| Investigation of Safety, Pharmacokinetics and Pharmacodynamics of Different Doses of BIWH 3 in Patients With Chronic Critical Limb Ischaemia (NCT02215824) | Boehringer Ingelheim | 2002-10-01 |
| Single Dose Escalation Study of Bivatuzumab Mertansine in Female Patients With CD44v6 Positive Metastatic Breast Cancer (NCT02254005) | Boehringer Ingelheim | 2002-10-01 |
| Acute Bronchodilator Response of a Single Dose of Atrovent or Berotec on Top of Pharmacodynamic Steady State of Spiriva (NCT00274066) | Boehringer Ingelheim | 2002-10-01 |
| Dose Finding Study of Pramipexole (Sifrol) in Patients With Idiopathic Restless Legs Syndrome (RLS) (NCT00239486) | Boehringer Ingelheim | 2002-10-01 |
| Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM (NCT00274612) | Boehringer Ingelheim | 2002-10-01 |
| Berodual® Respimat® Versus Berodual® Metered Aerosol (MA) Inhaler in Patients With Asthma, Chronic Obstructive Pulmonary Disease, or Mixed Condition (NCT02173795) | Boehringer Ingelheim | 2002-10-01 |
| Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects (NCT02211885) | Boehringer Ingelheim | 2002-10-01 |
| SPIRIVA in Ususal Care (NCT00274079) | Boehringer Ingelheim | 2002-10-01 |
| Efficacy and Safety of Pramipexole (PPX) in Moderate to Severe Idiopathic Restless Legs Syndrome (RLS) Patients (NCT00275457) | Boehringer Ingelheim | 2002-10-01 |
| Ipratropium Bromide/Salbutamol Delivered by the Respimat® Inhaler Compared to Ipratropium Bromide Respimat®, COMBIVENT® Inhalation Aerosol and Placebo in Adults With Chronic Obstructive Pulmonary Disease (NCT02177253) | Boehringer Ingelheim | 2002-10-01 |
| Headache Study to Compare Aggrenox Full Dose and Reduced Dose (NCT00274586) | Boehringer Ingelheim | 2002-09-01 |